Dr. Aliya Gulamhusein, MD, MPH FRCPC. Assistant Professor and Clinical Investigator, Toronto Centre for Liver Disease, Toronto General Hospital, University Health Network.

Dr. Gideon Hirschfield is a world-renowned autoimmune liver disease clinician and researcher, and he has extensive clinical expertise in the management of complex liver disease, pre- and post-transplant. He was recently awarded the inaugural Lily and Terry Horner Chair in Autoimmune Liver Disease Research at UHN’s Toronto Centre for Liver Disease and is leading the centre’s Autoimmune Liver Disease program along with Dr. Aliya Gulamhusein. This comprehensive program offers life-long care to patients with autoimmune hepatitis, primary biliary cholangitis, and primary sclerosing cholangitis, while advancing groundbreaking research

Dr. Marotta is the Medical Director of Liver Transplantation at the London Health Sciences Centre in London, Ontario and is the Co-Program Director of the Advanced Hepatology/Liver Transplantation Fellowship Program.

Dr. Andy Mason is a Professor of Medicine and an Alberta Heritage Foundation for Medical Research Senior Scholar. He trained at the Liver Unit, Kings College Hospital, in London, England and then moved to Washington University, St. Louis as a Gastroenterology Fellow to train in molecular virology. At Ochsner Clinic Foundation, New Orleans he became the Medical Director of Liver Transplantation and an Assistant Professor in the Department of Medicine, Tulane University Medical Center. He relocated to the University of Alberta in 2002 and is currently the Director Research for the Division of Gastroenterology and Director of The Applied Genomics Centre.

Dr. Magnus McLeod is an assistant professor in the Division of General Internal Medicine at Dalhousie University. As an internist, he has a strong clinical and academic interest in liver disease, particularly PBC and fatty liver disease.

Dr. Mark Swain has been a practicing hepatologist and clinician-scientist since his arrival in Alberta in 1993. He is Head of the University of Calgary’s Division of Gastroenterology and Hepatology and holds several other leadership roles, including the Cal Wenzel Family Foundation Chair in Hepatology (a research chair) and Head, Translational Research Core, Snyder Institute of Chronic Diseases. He is widely published in the areas of liver disease and autoimmunity with more than 110 peer-reviewed articles published to date.

Dr Jean Philippe Wallach, University of British Columbia, focuses on treating autoimmune liver disease in First Nations communities.